Therefore, the above-described data on the insignificant differences in MPO and H3cit levels in AS and PsA, and the increase in MPO but not H3cit in RA (Figure 2), may be associated with the effectiveness of bDMARDs. The gene discussed is MPO; the disease is rheumatoid arthritis.